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ABSTRACT 
Translation of mRNA is tightly regulated in cells to ensure that proteins are 
synthesized at the right time, in the right location, and at appropriate levels. Single-
molecule fluorescence in situ hybridization (smFISH) is a simple and widely used 
method to measure mRNA transcription through determining the abundance and 
localization of mRNAs in single cells. A comparable single-molecule in situ method 
to measure mRNA translation would enable a more complete understanding of gene 
regulation. In this thesis, we describe the development and characterization of a 
fluorescence assay to detect ribosome interactions with mRNA (FLARIM). The 
method adapts smFISH to visualize and characterize translation of single molecules 
of mRNA in fixed cells. To visualize ribosome-mRNA interactions, we use pairs of 
oligonucleotide probes that bind separately to ribosomes (via ribosomal RNA) and 
to the mRNA of interest, and that produce strong fluorescence signals via the 
hybridization chain reaction (HCR) when the probes are in close proximity. FLARIM 
does not require genetic manipulation, is applicable to practically any endogenous 
mRNA transcript, and provides both spatial and temporal information.  
We first characterize FLARIM in mouse fibroblast cells. We show that 
FLARIM is sensitive to changes in ribosome association with mRNA upon inhibition 
of global translation with puromycin. We also show that FLARIM detects changes 
in ribosome association with an mRNA whose translation is upregulated in response 
to increased concentrations of iron. Finally, we demonstrate FLARIM in mouse 
hippocampal neurons, in which local translation of mRNA in the neuronal processes 
is essential to cell growth and development. We first demonstrate FLARIM in 
neurons using probes for β-actin mRNA. We then show that FLARIM detects 
increased transcription and translation of activity regulated cytoskeletal protein (Arc) 
mRNA in response to neuronal activation with brain-derived neurotrophic factor 
(BDNF). We also compare the cellular distribution between the major microtubule-
associated protein 2 (MAP2) mRNA isoforms, whose translation will be 
characterized in future FLARIM experiments. Overall, this work expands the 
capability of smFISH to study mRNA translation in addition to transcription, and it 
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shows the utility of in situ translation analysis in characterizing single-cell gene 
expression.  
 vii 
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C h a p t e r  1  
INTRODUCTION 
1.1 Regulation of mRNA Translation 
Translation, the process by which ribosomes synthesize protein from an 
mRNA transcript, is tightly regulated in cells to ensure that proteins are produced at 
the right time and in the right place. In eukaryotes, translation occurs in the cytoplasm 
and is carried out by the ribosome, which consists of two subunits composed of RNA 
and protein: the small subunit (40S) and the large subunit (60S). The small subunit 
of the mammalian ribosome contains one RNA species (the 18S ribosomal RNA 
(rRNA)) and 33 proteins. The large subunit of the mammalian ribosome contains 
three RNA species (28S, 5.8S, and 5S rRNA) and 47 proteins1.  
Translation is divided into three major steps: initiation, elongation, and 
termination. During initiation, specific protein factors and a methionyl transfer RNA 
(Met-tRNA) first bind to the 40S subunit to form a 40S preinitiation complex that 
then associates with mRNA. The preinitiation complex binds to a methylated guanine 
(called the 5’ cap) in the  5’ untranslated region (5’ UTR) of most mRNAs2. However, 
for certain mRNAs and environmental conditions, the preinitiation complex can bind 
to an internal ribosomal entry site (IRES)3 instead of the 5’ cap.  After binding, the 
preinitiation complex scans down the mRNA transcript in the 5’ to 3’ direction to 
reach the initiator codon, which is the nucleotide sequence AUG. The preinitiation 
complex pauses and the 60S subunit joins to form the 80S initiation complex, which 
carries out the elongation process. During elongation, the 80S ribosome scans the 
mRNA one codon at a time to build the nascent polypeptide chain. At each codon, a 
tRNA with a complementary anticodon sequence binds. This tRNA carries a specific 
amino acid, which forms a peptide bond (catalyzed by the peptidyl transferase center 
in the 60S subunit) with the amino acid on the previous tRNA. The cycle of tRNA 
binding and peptide bond formation continues until the full polypeptide is 
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synthesized. Termination of translation occurs when the 80S ribosome reaches the 
termination codon, which is not recognized by any tRNA. Instead, a release factor 
binds to the stop codon and promotes disassembly of the ribosome and mRNA 
complex to ultimately release the final protein product2. 
Translation is regulated both spatially and temporally by localizing mRNAs 
to specific subcellular compartments and translating those mRNAs into functional 
protein at the appropriate time(s). This regulation allows cells to respond rapidly to 
their environment, and it controls important biological processes including 
embryonic development4, cell growth and migration5, cell stress6, and memory 
formation7. For example, early oogenesis and embryogenesis in Drosophila requires 
proper subcellular localization and subsequent translation of bicoid, nanos, oskar, and 
gurken mRNAs in the oocyte8. In Xenopus, asymmetric distribution of specific 
mRNAs in the oocyte establishes the body plan for the embryo and is critical to 
normal development9. In addition to organismal development, translational 
regulation is important to trigger cell stress responses and cell movement. During the 
unfolded protein response (UPR) in cells, several mRNAs are selectively upregulated 
in translation while the majority are downregulated10,11. In particular, activating 
transcription factor 4 (ATF4) mRNA switches from a translationally silent state to a 
highly active state without changes in its mRNA level during cell stress through a 
mechanism in which ribosomes are able bypass an inhibitory upstream open reading 
frame (uORF) in the transcript12. One of the most well characterized mRNAs that 
undergoes local translation to control cell growth and motility is Beta-actin (β-actin), 
which localizes to the leading edge of several different cell types. For instance, in 
chicken embryo fibroblasts, β-actin mRNA localizes to lamellipodia, and inhibition 
of this localization results in reduced cell motility13–15. β-actin mRNA appears at cell 
adhesions in mouse fibroblasts as well, and cell movement is enhanced or reduced 
when β-actin is concentrated at or displaced from these adhesions, respectively16. β-
actin mRNA also localizes to dendrites in neurons and is required for neurite 
growth17,18. In addition to β-actin, thousands of different mRNAs have been 
identified in dendrites and or axons19, and translation in these compartments allows 
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neurons to respond to their local environment20. Multiple studies have reported that 
translation of specific mRNAs in dendrites or axons helps form memories7,21,22. One 
example mRNA is calcium/calmodulin-dependent protein kinase II alpha 
(CamKIIα). When the 3’UTR of CamKIIα is mutated such that the mRNA and 
protein are restricted to the soma instead of dendrites, mice demonstrate impaired 
spatial memory, fear conditioning, and object recognition memory23. Fully 
understanding the role of translational regulation in these and other biological 
phenomena requires techniques to detect and quantify mRNA translation in a cellular 
context. 
 
1.2 Techniques to measure mRNA Translation 
Transcription and translation of mRNA can be measured with both ensemble 
and single-cell techniques. Global mRNA transcription is most commonly measured 
using RNA sequencing (RNA-seq). With RNA-seq, RNA is isolated from 
homogenized cells or tissues and is converted into cDNA via reverse transcription. 
The cDNA fragments are then sequenced to determine the mRNA species that were 
expressed and their relative abundances24. Another common tool to measure global 
transcription is a DNA microarray, which consists of a solid surface containing 
discrete spots of single-stranded DNA probes. The sequence of the probes in each 
spot corresponds to a specific gene in the sample of interest25. The microarray can be 
designed to cover an entire genome26. To measure transcription, purified mRNA 
from cell or tissue samples is reverse transcribed into cDNA, fluorescently labeled, 
and added to the microarray. The cDNAs hybridize to their complementary DNA 
probes on the microarray, thereby producing a fluorescence readout at the microarray 
spots containing those probes. The fluorescence intensity of each spot provides a 
relative measure of mRNA expression level25. 
In order to measure mRNA translation at the ensemble level, methods to 
quantify ribosome association with mRNA have been developed. Two common 
methods are polysome fractionation and ribosome profiling. Polysome fractionation 
determines the translation efficiency of a particular mRNA, whereas ribosome 
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profiling determines which mRNAs in a sample are being actively translated. In 
polysome fractionation, ribosomes are separated into polysome and non-polysome 
fractions using sucrose density gradient centrifugation. The relative abundances of 
an mRNA in the polysome and non-polysome fractions is then measured via 
Northern blot or reverse transcription polymerase chain reaction (RT-PCR)27. In 
ribosome profiling, mRNA fragments bound by ribosomes are isolated and 
sequenced to identify which mRNAs are translated and the relative level of their 
translation, as well as to which mRNA regions ribosomes bind28–30.  
In addition to techniques that detect ribosome association with mRNA, 
methods to identify and quantify proteins in a sample can be used to assess translation 
levels. Traditional quantitative proteomics is performed with two-dimensional gel 
electrophoresis (2-DE) and or mass spectrometry (MS). 2-DE separates proteins in a 
sample by both their isoelectric points and molecular weights31. Once proteins have 
been separated, the resulting gel bands can be compared between samples to identify 
proteins that are more or less abundant. These proteins can be identified from gel 
databases, such as the Swiss 2D-PAGE database. More commonly, the proteins are 
excised from the gel, digested, and analyzed by MS. With MS, proteins from a 
sample are ionized and their mass-to-charge ratio is measured to identify individual 
proteins and quantify their abundance32. Stable isotope labeling by amino acids in 
cell culture (SILAC) and bioorthogonal noncanonical amino acid tagging 
(BONCAT) are additional MS-based proteomic methods that can detect differences 
in protein abundance between samples and identify newly synthesized proteins, 
respectively33,34. 
These ensemble methods to measure mRNA transcription and translation are 
valuable to understand genome-wide expression levels within a population of cells. 
However, because these methods require tissue homogenization and or cell lysis, they 
do not provide information about the subcellular localization of transcription and 
translation. They also do not measure differences in gene expression between 
individual cells in a heterogeneous population. Gaining insight into local gene 
regulation in single cells requires in situ methods. 
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Fluorescence in situ hybridization (FISH) is a widely used method to study 
mRNA expression in fixed cells and tissue samples. FISH utilizes fluorescently 
labeled oligonucleotides (either DNA or RNA) that hybridize a target mRNA 
sequence and thereby produce a fluorescent signal at the site of the mRNA. 
Traditional FISH probes are 200-600 nucleotides long. They are generated by vector 
expression or PCR followed by nick translation, in vitro transcription, or random-
primed DNA synthesis to incorporate nucleotides bearing fluorescent tags into the 
probes35. Because the probes are relatively long and therefore have low target 
specificity, traditional FISH is often limited to longer, higher copy transcripts and 
results in a broad staining pattern in cells36,37. More recently, single molecule FISH 
(smFISH) has been developed to detect individual mRNAs inside single cells38,39. 
smFISH utilizes multiple short, single-stranded and singly-labeled DNA probes that 
hybridize to an mRNA of interest. Probes are generally 20 nt long, and up to 48 
probes are designed per mRNA transcript. Single molecules of a target mRNA are 
then visible as diffraction-limited fluorescent spots under a fluorescence 
microscope39. Various methods such as hybridization chain reaction (HCR) and 
RNAscope can be used to enhance the brightness and specificity of smFISH 
signals40,41. Most recently, single-molecule hybridization chain reaction (smHCR) 
has been used to generate bright, robust signals for detection of mRNA in cultured 
cells as well as in thick tissue samples42. Compared to smFISH, which uses probes 
carrying a single fluorophore, smHCR uses probes containing a single-stranded 
initiator sequence that binds and opens fluorescently labeled DNA hairpins. These 
hairpins assemble into a fluorescent polymer, resulting in a bright fluorescent signal 
at the site of amplification. 
FISH methods detect and quantify mRNA, but they do not indicate whether 
mRNAs are translated into functional protein or not. Antibody staining is a common 
approach to visualize proteins and quantify their relative abundance in situ43,44, but 
this method does not provide a direct measure of translation. Global protein synthesis 
can be monitored in situ with puromycylation and fluorescent noncanonical amino 
acid tagging (FUNCAT). For puromycylation, cells are treated with a low 
  
6 
concentration of the tRNA analog puromycin, which is recognized by the ribosome 
and incorporated into nascent peptide chains. Cells are fixed, and the puromyclated 
peptides are labeled with a fluorescent anti-puromycin antibody45,46. Alternatively, 
puromycin conjugated with fluorophores is used47. FUNCAT follows a similar 
procedure but uses amino acid analogues instead of puromycin. Cells are treated with 
chemically modified amino acids, which are incorporated into newly synthesized 
proteins by the cells’ endogenous protein synthesis machinery. Cells are fixed and 
the amino acid analogues are coupled to fluorophores to highlight the cellular 
locations and relative level of protein synthesis48. Puromycylation and FUNCAT can 
also be combined with the proximity ligation assay (PLA) to detect translation of 
specific proteins in situ49,50. 
Puromycylation and FUNCAT require fixed cells. To visualize translation in 
live cells, the cell-permeable biarsenical dyes FlAsh and ReAsh have been 
developed. These dyes become fluorescent when they covalently react with a 
tetracysteine peptide motif that is genetically encoded into a protein of interest51,52. 
However, labeling with FlAsh and ReAsh does not provide information about the 
protein’s corresponding mRNA. More recent live-cell imaging techniques utilize 
dual labeling systems in which an mRNA is genetically tagged with RNA stem loops 
to which a fluorescently-labeled coat protein binds, and the interaction of the mRNA 
with ribosomes is detected by colocalization of a second label53–55. In addition, live-
cell imaging methods that simultaneously detect an mRNA and its nascent 
polypeptide product have been developed. In these methods, a reporter mRNA 
contains stem loops to which a genetically-encoded fluorescent protein binds, and the 
mRNA’s peptide contains epitope tags to which genetically-encoded fluorescent 
antibodies bind56–60. Colocalization of fluorescence signals from the mRNA and its 
nascent polypeptide indicates active translation of that mRNA. These methods 
provide single-molecule resolution of mRNA translation in single living cells. 
However, they are limited to reporter mRNAs rather than endogenous transcripts. 
They also require cloning that may not be feasible for all cell types and mRNAs of 
interest and may affect cellular behavior. 
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We sought to develop a method that monitors mRNA translation in single 
cells and addresses the limitations of these existing methods. We decided to utilize 
RNA in situ hybridization and the hybridization chain reaction in a manner that 
produces bright fluorescence when ribosomes are bound to an mRNA of interest in 
fixed cells. We termed our method FLARIM, for fluorescence assay to detect 
ribosome interactions with mRNA. In Chapter 2, we describe FLARIM in detail and 
characterize its performance in mouse fibroblast cells. We demonstrate that FLARIM 
detects changes in translation of specific mRNAs under different environmental 
conditions, and we speculate that FLARIM can provide insights about local mRNA 
translation, a well-known phenomenon in neurons.  We then address this application 
in Chapter 3 by using FLARIM in primary mouse hippocampal neurons. We study 
the mRNAs for β-actin, activity-regulated cytoskeleton-associated protein (Arc), and 
microtubule-associated protein 2 (MAP2). 
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C h a p t e r  2  
USING FLUORESCENCE IN SITU HYBRIDIZATION TO 
QUANTIFY MRNA TRANSLATION IN SINGLE CELLS 
Published as: 
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method to quantify mRNA translation by visualizing ribosome-mRNA interactions 
in single cells.” ACS Central Science, 2017, DOI: 10.1021/acscentsci.7b00048 
 
2.1 Summary 
Precise spatiotemporal control of mRNA translation is critical for regulating 
cellular processes. Single-molecule detection of mRNA via fluorescence in situ 
hybridization (FISH) has revealed when specific mRNAs are produced and where 
they are located in cells. However, current FISH methods cannot determine when and 
where these single molecules of mRNA are translated into protein. While live-cell 
imaging techniques have been developed to track when an mRNA associates with 
ribosomes or produces its peptide product, these techniques require genetic 
manipulation that may be difficult and time-consuming to accomplish. In addition, 
the methods are not applicable to fixed samples. We sought to develop a simple, 
inexpensive method to visualize and quantify changes in mRNA translation in fixed 
cells. Our method – termed FLARIM, for fluorescence assay to detect ribosome 
interactions with mRNA – utilizes RNA in situ hybridization and the hybridization 
chain reaction to produce bright fluorescence when ribosomes are bound to an 
mRNA of interest. FLARIM is applicable to any endogenous mRNA in cells and 
does not involve any structural or genetic perturbations. We demonstrate that 
FLARIM effectively detects changes in mRNA translation of specific genes under 
different environmental conditions. FLARIM also inherently measures mRNA 
transcription, thereby providing greater insight into two fundamental processes of 
gene expression. 
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2.2 Introduction 
Gene expression is regulated at both the transcriptional and translational 
levels. For many genes, changes in mRNA and protein levels are not correlated1–4, 
and protein abundance is often dominated by translation rather than transcription5. 
Translational regulation is necessary to coordinate the timing, amount, and location 
of protein synthesis, and is essential to biological processes including cell 
morphogenesis and migration6,7, organismal development8, responses to cell stress9, 
and memory formation10. 
Ensemble biochemical methods are widely used to measure global changes 
in mRNA transcription and translation in cells. The most common method for 
transcriptomic analysis is RNA-seq11. Ribosome profiling is an extension of RNA-
seq in which mRNA fragments bound by ribosomes are isolated and sequenced to 
assess mRNA translation3,12,13. The translation efficiency of a particular mRNA can 
also be determined by fractionating ribosomes using sucrose density gradient 
centrifugation and measuring the relative abundances of the mRNA in the polysome 
and non-polysome fractions14. These methods measure genome-wide expression 
levels in populations of cells (although RNA-seq has been modified to measure 
mRNA expression in single cells as well15). Because these methods require cell 
disruption, they provide no information about subcellular localization of transcription 
and translation for particular genes. In order to study local gene regulation, in situ 
methods that detect mRNA and protein within cells are required. 
Various in situ fluorescence imaging techniques have been developed to 
study transcription and translation in single cells with spatial and temporal 
resolution16. Transcription is commonly measured with single-molecule fluorescence 
in situ hybridization (smFISH), in which mRNAs are probed with fluorophore-
labeled DNA oligonucleotides so that their numbers and locations in single cells can 
be quantified. Several methods have been developed to enhance the brightness and 
specificity of smFISH17,18. Recently, the single-molecule hybridization chain 
reaction (smHCR) has been developed to achieve bright, robust signals for detection 
of mRNA in cultured cells as well as in thick tissue samples19. Changes in protein 
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translation can be measured via 35S-methionine labeling20, bioorthogonal non-
canonical amino acid tagging (BONCAT)21,22 or puromycylation23–25. The latter 
methods can be combined with the proximity ligation assay (PLA)26 to detect 
translation of specific proteins in situ27, but none of these approaches provides 
information about mRNA abundance or location. 
Live-cell fluorescence imaging techniques have utilized dual labeling 
systems in which an mRNA is genetically tagged with stem-loop recognition 
elements (MS2 or PP7 stem loops) to which a fluorescently-labeled coat protein 
binds, and the interaction of the mRNA with ribosomes is detected by colocalization 
of a second label28–30. Recently, multiple live-cell imaging methods have been 
developed to simultaneously detect an mRNA and its nascent polypeptide product. 
Here, a reporter mRNA contains MS2 or PP7 stem loops and the nascent polypeptide 
encodes an array of epitope tags to which genetically-encoded fluorescent antibodies 
bind31–35. Colocalization of fluorescence signals from an mRNA and its nascent 
polypeptide indicates active translation of that mRNA. These methods are the first to 
provide single-molecule resolution of mRNA translation events in single living cells. 
However, they are limited to monitoring reporter mRNAs rather than endogenous 
transcripts. The cloning required to implement these methods may affect cellular 
behavior and may not be feasible for all cell types and mRNAs of interest. 
We have developed an imaging method that uses RNA in situ hybridization 
and the hybridization chain reaction (HCR) to probe translation of unmodified 
endogenous mRNA transcripts in single fixed cells (Figure 1A). We call this method 
FLARIM, for fluorescence assay to detect ribosome interactions with mRNA. 
FLARIM reveals interactions between individual mRNAs and ribosomes to provide 
a measure of the extent of active translation of the target mRNA species. The method 
does not require genetic manipulation of cells and can be applied to almost any 
mRNA of interest. As ribosome profiling extends RNA-seq to quantify mRNAs 
bound by ribosomes, FLARIM extends smFISH to identify ribosome-bound mRNAs 
and to monitor the changes in ribosome-mRNA interaction that accompany cellular 
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perturbations. Because FLARIM yields images of fixed cells, the subcellular 
locations where mRNAs interact with ribosomes can be determined.  
Here we introduce and characterize FLARIM in NIH 3T3 mouse fibroblasts. 
We first demonstrate the method by detecting the interaction of β-actin mRNA with 
ribosomes, and by probing how this interaction changes upon treatment with the 
translation inhibitor puromycin. Both the fraction of mRNAs bound to ribosomes and 
the intensities of individual interaction signals decrease. We then examine 
translational regulation of ferritin heavy chain (FTH1) mRNA in response to added 
iron. We observe an increase in ribosome-mRNA interaction over a 24-h iron 
incubation period. We also note a small increase in FTH1 mRNA copy number for 
cells treated with iron, in contrast to previous reports that FTH1 mRNA levels are 
unchanged by addition of iron36,37. FLARIM thus provides both spatial and temporal 
information about two of the key steps in regulation of gene expression. 
 
2.3 Results and Discussion 
To visualize ribosome-bound mRNAs, we use pairs of oligonucleotide 
probes that bind separately to ribosomes (via ribosomal RNA) and to the mRNA of 
interest, and that produce strong fluorescence signals via the hybridization chain 
reaction (HCR) when in close proximity (Figure 2.1A). Ribosomes are hybridized 
with multiple oligonucleotide probes that bind to 18S ribosomal RNA (rRNA). We 
used the mouse rRNA secondary structure of Holmberg et al.38 to identify regions on 
the 18S rRNA that are relatively unstructured and that contain bases shown to be 
accessible for chemical modification. We preferentially targeted our ribosome probes 
to these regions and designed 24 unique probes in total. We verified that the 
corresponding sense probes for 18S rRNA do not produce fluorescence via FISH 
(Figure 2.S1). An mRNA of interest is hybridized with two different sets of 
oligonucleotide probes: one (designated “mRNA interaction probes”) that pairs with 
the ribosome probes to form binding sites for a linker probe that carries an HCR 
initiator, and a second (“mRNA transcript probes”) that separately labels the mRNA 
transcript with a different HCR initiator. Interaction probes are targeted to the coding 
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sequence (CDS), the region of the mRNA that is translated by ribosomes. Transcript 
probes are primarily targeted to untranslated regions (5’UTR and 3’UTR) of the 
mRNA. We targeted each mRNA region with 15 - 36 probes. Multiple probes are 
used per target in order to increase the signal to noise ratio and to discriminate signal 
arising from true mRNAs from signal resulting from nonspecific binding of 
individual probes39,40. Sequences of all oligonucleotide probes used in this study are 
listed in Supplemental Table 1. 
Each mRNA transcript probe contains an HCR initiator sequence and a 25-
nucleotide (nt) region complementary to the mRNA. In HCR, a single-stranded 
initiator sequence is used to bind and open fluorescently labeled DNA hairpins that 
then assemble into a fluorescent polymer, resulting in a bright fluorescent signal at 
the site of amplification. Choi and coworkers have introduced five unique HCR 
initiator sequences (designated B1-B5), each with a corresponding pair of HCR 
hairpins for fluorescence amplification17. We used the B2 HCR initiator and its 
corresponding hairpins coupled to Alexa Fluor 488 for all mRNA transcript probes 
(Figure S2, Table S1). Each mRNA interaction probe and each ribosome probe 
contains a 25-nt region complementary to its target RNA, a 13-nt polyA spacer, and 
a 22-nt extension sequence. A common extension sequence is used for all mRNA 
interaction probes, and a different extension sequence is used for all ribosome probes 
(Figure 2.S2, Table 2.S1). 
Extension sequences on the mRNA interaction and ribosome probes are 
hybridized with an oligonucleotide linker probe bearing a 26-nt binding sequence 
that spans both extensions when they are in close proximity (15 nt hybridize to the 
mRNA extensions; 11 nt hybridize to the ribosome extensions) (Figure 2.S2). The 
binding strength of the linker is tuned with formamide, which lowers the melting 
temperature of DNA41. The amount of formamide in solution during the linker 
hybridization step and subsequent wash steps is adjusted such that the linker remains 
bound when it spans both extension sequences but not when it hybridizes only one 
extension (Figure 1A). We determined the appropriate amount of formamide by 
titrating it in our wash solution and our hybridization buffer during the linker 
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hybridization step. We found that 35% formamide removed the most background 
signal without comprising hybridization of mRNA transcript probes (Figure 2.S3). 
The linker probe also contains an HCR initiator sequence. We used the B3 
HCR initiator and its corresponding HCR hairpins coupled to Alexa Fluor 546 to 
amplify fluorescence signals associated with the linker probe. Signals from the linker 
probes and from mRNA transcript probes appear as single, diffraction-limited spots 
when visualized by confocal microscopy (Figure 2.1C). In the ideal FLARIM 
scheme, spots that colocalize in the Alexa 488 (shown in red throughout this study) 
and Alexa 546 (shown in green throughout this study) channels indicate mRNAs 
bound to ribosomes; spots that appear only in the Alexa 488 channel indicate mRNAs 
that do not interact with ribosomes. On the basis of the assumption that three 
nucleotides add ~1 nm to the length of a DNA probe42, we estimated that ribosome 
probes and mRNA interaction probes must be separated by no more than ~18 nm if 
they are to produce interaction signals. 
We first tested FLARIM in situ in NIH 3T3 fibroblasts, using probes designed 
for β-actin mRNA. Control experiments in which either the mRNA interaction probes 
or the ribosome probes were omitted showed little or no labeling from the linker 
probe, consistent with our expectation that the linker can be effectively washed out 
of cells when it binds only to an mRNA interaction probe or to a ribosome probe. 
However, when both probe sets were present, we saw a significant increase in signal 
from the linker probe (Figure 2.1B) and substantial colocalization of these signals 
with those derived from the β-actin transcript probes (Figure 2.1C). We found on 
average that 61 ± 4% (n = 21 cells) of β-actin transcripts in the cytoplasm were 
colocalized with ribosomes.  
We examined β-actin transcript probes in control experiments with either 
ribosome probes or mRNA interaction probes to ensure that signals from the 
combination of the latter two probe sets showed significantly higher colocalization 
to β-actin transcripts than to background signals from either probe set alone. Both 
sets of HCR hairpins were added to all control experiments.  Samples with ribosome 
probes or mRNA interaction probes alone produced punctate Alexa 546 emission to 
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which only 8 ± 1% (n = 10 cells) and 7 ± 2% (n = 11 cells) of Alexa 488 spots 
colocalized, respectively (Figure 2.1D, Table 2.S3). We also checked potential 
background colocalization from the linker probe. Cells treated with the linker probe 
alone produced spots of Alexa 546 emission that colocalized to fewer than 1% (n = 
11 cells) of Alexa 488 spots (Table 2.S3).  We conclude that the levels of false 
positive signals arising from nonspecific binding of the linker, or from the HCR 
amplification step, are low. As a further check on the method, we analyzed ribosome 
interaction with β-actin mRNA in cell nuclei, where translation is  not expected to 
occur. We found that only 12 ± 12% (n = 10 cells) of β-actin transcripts in cell nuclei 
colocalized with ribosome signal, consistent with the results of the control 
experiments described above (Figure 2.S4). The uncertainty in the measurement of 
nuclear colocalization arises from the small number (average of 11 ± 4 spots per 
nucleus for 10 cells) of β-actin mRNA spots in the nucleus. To determine the utility 
of FLARIM for the study of transcripts characterized by lower copy numbers, we 
examined Actin-related protein 3 (Arp3) mRNA, which is ~10X less abundant than 
β-actin mRNA (we measured an average of 190 Arp3 mRNAs per cell, n = 31 cells). 
As with β-actin, we found that the fraction Arp3 transcripts that colocalized to 
background signal from ribosome or mRNA interaction probes alone was at least 8X 
lower than the fraction that colocalized to signal from the combination of both probe 
sets (Figure 2.S5). 
The percentage of cytoplasmic β-actin transcripts observed to bind ribosomes 
(61 ± 4%) is almost certainly an underestimate. Fluorescence signals generated by 
smFISH and smHCR invariably yield less than 100% colocalization for probes 
targeted to the same message19,39,43. For example, Shah and coworkers found that 
when using three sets of smHCR probes per transcript, approximately 85% of spots 
from a single channel colocalized with spots from at least one other channel19. To set 
an upper bound on the extent of ribosome-mRNA interaction to be expected in our 
β-actin experiments, we performed another control experiment in which we replaced 
the linker probe (which hybridizes to only 15 nt of the mRNA interaction probe) with 
a linker complementary to 24 nt of the interaction probe (see Figure 2.S6 schematic). 
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This experiment showed 74 ± 3% of Alexa 488 spots to colocalize with spots in the 
Alexa 546 channel (Figure 2.S6).  This result indicates that the measured value of 61 
± 4% is indeed an underestimate of the percent of cytoplasmic β-actin transcripts 
bound to ribosomes. Our results are consistent with the polysome profiling data of 
Ventoso and coworkers, who found the fraction of β-actin mRNAs associated with 
polysomes in NIH 3T3 cells to be 0.7244. 
We tested the sensitivity of FLARIM to changes in ribosome-mRNA binding 
by treating cells with puromycin, a translation inhibitor that causes dissociation of 
ribosomal subunits from mRNA45. The effect of puromycin is apparent in a 
comparison of side-by-side images of treated and untreated cells (Figure 2.2A). Cells 
treated with puromycin show less colocalization (yellow) between transcript spots 
(red) and ribosome-mRNA interaction spots (green). The percentage of β-actin 
transcripts interacting with ribosomes in the cytoplasm decreased from 61 ± 4% in 
control cells to 38 ± 6% in puromycin-treated cells (Figure 2.2B). Furthermore, the 
intensities of the fluorescence signals associated with single ribosome-mRNA 
interaction spots shifted to lower values (Figure 2.2C), indicating a reduction in the 
number of ribosomes bound per β-actin transcript.  
The observed changes in signal colocalization and signal intensity with 
puromycin treatment demonstrate the sensitivity of the FLARIM method to 
perturbations in ribosome association with mRNA. We found no change in the 
average number of β-actin mRNAs per cell after puromycin treatment (Figure 2.S7). 
We measured an average of ~2000 β-actin transcripts per cell, in agreement 
Schwanhäusser’s estimate of ~2200 β-actin transcripts per NIH 3T3 cell, as 
determined by mRNA sequencing5. We also found no change in the fraction of 
ribosome-mRNA interaction spots colocalizing with β-actin transcript spots after 
puromycin treatment (Table 2.S5). To estimate the total change in ribosome 
interaction with β-actin mRNA after puromycin treatment, we multiplied the fraction 
of β-actin mRNAs colocalized with ribosomes by the average intensity of the 
associated Alexa 546 spots. Since multiple mRNA interaction probes are used, a 
decrease in ribosome association with mRNA could result in fewer of these probes 
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per mRNA forming a successful interaction with ribosomes. A ribosome-mRNA 
interaction signal could still be produced, but it would have a lower fluorescence 
intensity. We observed a 2.6-fold decrease in ribosome interaction based on this 
metric (average of two independent experiments, n = 7-16 cells per condition per 
experiment). As an additional check on the sensitivity of FLARIM measurements to 
changes in ribosome association with mRNA, we treated cells with both puromycin 
and 4E1RCat, which inhibits formation of the translation initiation complex and 
hence prevents recruitment of the small ribosomal subunit to mRNA46. The 
percentage of β-actin transcripts interacting with ribosomes in this experiment 
dropped to 23 ± 5% (Figure 2.S8), indicating that the signal observed with puromycin 
treatment alone may have reflected binding of the small ribosomal subunit to the 5’ 
UTR of β-actin mRNA. 
We subjected the FLARIM method to a second test by examining the 
translational regulation of ferritin synthesis in response to iron treatment47. Under 
standard conditions in cell culture, ferritin heavy chain (FTH1) mRNA is 
translationally repressed by binding of an iron regulatory protein (IRP) to an iron 
response element (IRE) in the 5’UTR. Upon addition of iron, the IRP is released from 
the IRE, ribosomes bind to the mRNA, and FTH1 is efficiently translated5,48,49 
(Figure 2.3A). Increases in FTH1 protein levels in mammalian cells in response to 
elevated iron are attributed to increased translation (not transcription), as the levels 
of FTH1 mRNA have been shown to remain constant36,37. 
We used hemin, an iron porphyrin, as the source of iron. When added to cells 
in culture, hemin rapidly releases iron intracellularly, and has been shown to induce 
ferritin synthesis36. We added hemin at a final concentration of 50 µM to cell culture 
media and fixed cells after different periods of time. Western blotting confirmed that 
the FTH1 protein level increased upon addition of hemin (Figure 2.S9). In companion 
FLARIM experiments, we detected a noticeable increase in interaction of the FTH1 
mRNA with ribosomes in cells treated with hemin (Figures 2.3B). After 4 h of 
treatment, the fraction of FTH1 mRNAs interacting with ribosomes per cell doubled, 
from 21 ± 4% in vehicle-treated cells to 43 ± 7% in cells incubated with hemin. The 
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extent of increased interaction was essentially constant over 24 h (Figure 2.3C). The 
intensities of the fluorescence signals associated with single ribosome-mRNA 
interaction spots also shifted to higher values (Figure 2.3D, Figure 2.S10). We found 
no significant colocalization of FTH1 transcript signals to background signals in 
control experiments containing only ribosome probes or only mRNA interaction 
probes (Table 2.S4). We also found no difference in the fraction of ribosome-mRNA 
interaction spots colocalizing with FTH1 transcript spots between vehicle-treated and 
iron-treated cells (Table 2.S6). 
As discussed previously with respect to β-actin, FLARIM almost certainly 
provides underestimates of the fractions of ribosome-bound transcripts, owing to 
imperfect colocalization of the mRNA transcript and interaction probes (Figure 
2.S6). Nevertheless, the method reveals distinct increases in ribosome association 
with FTH1 when translation of the mRNA is upregulated.  Our finding that FTH1 
transcripts are translated at a lower rate than β-actin transcripts is consistent with the 
polysome profiling data reported by Ventoso et al., who found that only about 6% of 
FTH1 mRNAs are associated with polysomes in NIH 3T3 cells in the absence of iron 
treatment44. 
As before, we estimated the change in ribosome interaction with FTH1 
mRNA after addition of iron by multiplying the fraction of FTH1 mRNAs 
colocalized with ribosomes by the average intensity of the associated Alexa 546 spots 
for each treatment condition. After 4 h, 12 h, and 24 h of iron treatment, we observed 
2.7-, 2.2-, and 2.3-fold increases, respectively, in ribosome interaction with FTH1 
mRNA compared to the vehicle control (average of three independent experiments, 
n = 10-17 cells per condition per experiment). 
We detected an average of ~1000 FTH1 transcripts per NIH 3T3 cell in our 
vehicle control condition. In comparison, Schwanhäusser et al. estimated ~2200 
FTH1 transcripts per NIH 3T3 cell in media with no added iron5. Although several 
previous studies report that FTH1 mRNA levels in mammalian cells are unchanged 
upon iron treatment36,37, we observed a slight but statistically significant (P<0.0002 
at 4 h, P<0.0001 at 12 h and 24 h) increase in the number of FTH1 mRNAs per cell 
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after iron treatment (Figure 2.3E). On average, cells treated with iron for 4 – 24 h 
contained roughly 40% more copies of FTH1 mRNA than untreated cells. This 
modest increase in mRNA may not have been detectable with previous studies, which 
used northern blotting for quantification of FTH1 mRNA abundance36,37. The 
increase may also be a unique response in NIH 3T3 cells under our experimental 
conditions. Studies that suggest unchanged levels of FTH1 mRNA upon treatment 
with iron have focused on rat liver cells and transgenic mouse fibroblasts36,37,50. 
However, an investigation of Friend erythroleukemia cells (FLCs) found that FTH1 
mRNA expression increased by up to 10-fold upon treatment with hemin51.  The fact 
that FLARIM reveals changes in both mRNA interaction with ribosomes and mRNA 
copy number illustrates the utility of the method in assessing both translational and 
transcriptional control of gene expression in single cells. 
 
2.4 Conclusions 
This study shows that changes in ribosome association with endogenous, 
unmodified mRNAs can be imaged and quantified in situ using standard DNA 
oligonucleotide probes and HCR. We characterized this method, which we termed 
FLARIM, in NIH 3T3 mouse fibroblasts. We first measured ribosome-mRNA 
interactions for β-actin in single cells and detected a decrease in these interactions 
when cells were treated with the translation inhibitor puromycin. We observed no 
significant ribosome-mRNA interactions in cell nuclei, where translation is not 
expected to occur, although a few studies report conflicting evidence24,52. We also 
detected increased ribosome binding to FTH1 mRNA when cells were treated with 
iron, and surprisingly, we noted an increase in FTH1 mRNA levels in concert with 
the increase in ribosome interaction. Because FLARIM interrogates both 
transcriptional and translational processes, it has the potential to provide unique 
insights into the nature of gene regulation in single cells. Although FLARIM was 
applied only to mouse cells in this study, we designed a nearly identical set of 
ribosome probes for human 18S rRNA (Table 2.S2) to facilitate FLARIM studies in 
human cells. 
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FLARIM is simple and inexpensive, uses commercially available reagents 
and common laboratory equipment, and requires no genetic manipulation of the cells 
of interest. Experiments can be completed in 2-3 days from cell fixation to image 
collection and analysis. Compared to various proximity ligation assays53,54, which 
could conceivably be adapted to analyze interactions between ribosomes and mRNA, 
FLARIM requires fewer steps and is enzyme-free, making it cheaper and easier to 
modify for different sample types. The method is also amenable to the study of fixed 
clinical samples, which are inaccessible to techniques that require cloning. We 
anticipate that FLARIM will be especially useful in studies of local mRNA 
translation. For example, neurons contain thousands of different mRNA transcripts 
in their dendrites and or axons55, and FLARIM is well suited to the monitoring of 
changes in ribosomal association of these transcripts in response to external stimuli. 
In similar fashion, studies of local translation during embryonic development56 
should prove fruitful. 
FLARIM should be applicable to essentially any mRNA of interest; however, 
it does require that the mRNA be efficiently hybridized with oligonucleotide probes. 
It is conceivable that short mRNAs may not bind a sufficient number of probes to 
produce reliable signals. Using a higher number of probes is known to improve the 
robustness of mRNA detection39 and to increase the ratio of signal to 
autofluorescence40, although the number of probes needed for reliable mRNA 
detection may depend on the target transcript. It is also important to note that 
FLARIM does not yield a numerically accurate measure of the number of mRNAs 
being translated in the cell. Rather, it provides an approximate measure of translation, 
useful for comparisons among samples, along with spatial information and a measure 
of mRNA copy number. We use ribosome interaction as a proxy for translation, but 
it is known that mRNAs can be bound by ribosomes without being translated, e.g. in 
the case of ribosome stalling57. 
It should be straightforward to modify the FLARIM method to enable studies 
of other molecular interactions in single cells. In addition to RNA-RNA interactions, 
protein-RNA and protein-protein interactions can be revealed by using antibodies 
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conjugated to DNA oligonucleotides or by using aptamer probes58. Interactions with 
DNA might be measured by combining the method with DNA FISH techniques. The 
method is designed in a manner that makes it highly tunable. In adapting the method 
to detect interactions between different molecular species and in different cell types, 
the probe sequences and the stringency of the wash buffer can easily be adjusted to 
lower background and ensure that HCR amplification occurs essentially only from 
interacting probe pairs. Probe sequences can also be engineered to increase or 
decrease the maximum distance between probes that allows for signal generation. 
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2.6 Figures 
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Figure 2.1 (previous page): Illustration of FLARIM. (A) Schematic of method to 
detect ribosome-mRNA interactions in situ. Multiple DNA oligonucleotide probes 
are hybridized to ribosomes via rRNA and two different mRNA regions. For 
illustration purposes, only a single probe per ribosome and mRNA region is shown. 
Top: When an mRNA is bound by ribosomes, the linker probe can hybridize across 
the extension sequences of both the ribosome probes and the mRNA interaction 
probes, and thereby produce a fluorescence signal via HCR. Bottom: When an 
mRNA is not bound by ribosomes, the linker probe hybridizes weakly to extensions 
on the ribosome probes and the mRNA interaction probes and can be washed out of 
cells. (B) NIH 3T3 fibroblasts hybridized with either ribosome probes, mRNA 
interaction probes to β-actin, or both ribosome and β-actin mRNA interaction probes 
(top, green, Alexa 546 fluorescence). Cells are simultaneously hybridized with β-
actin transcript probes (middle, red, Alexa 488 fluorescence). Nuclei are stained with 
DAPI (blue). Merge of ribosome-mRNA interaction signals and transcript signals 
(bottom). Scale bar = 10 µm. (C) Zoom of single mRNA molecules. Red spot: mRNA 
transcript without ribosome interaction. Yellow spots: mRNA transcripts with 
ribosome interaction. Scale bar = 1 µm. (D) Fraction of β-actin transcript spots 
colocalized with ribosome-mRNA interaction spots. Error bars, standard deviation. 
Data represents two independent experiments, n = 10 or 11 cells per experiment. 
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Figure 2.2 (previous page): The translation inhibitor puromycin causes a significant 
decrease in ribosome-mRNA interaction as detected by FLARIM. (A) Ribosome-
mRNA interaction images for β-actin in NIH 3T3 cells that were either untreated 
(left) or treated (right) with puromycin at 200 µg/mL for 1 h. In the puromycin 
sample, there is a noticeable decrease in detectable colocalization (yellow) between 
β-actin mRNA transcript signals (red, Alexa 488 fluorescence) and ribosome-mRNA 
interaction signals (green, Alexa 546 fluorescence). Top, scale bar = 20 µm. Bottom, 
scale bar = 2 µm.  (B) Fraction of β-actin mRNA transcript spots per cell colocalized 
with a ribosome-mRNA interaction spot, with and without puromycin treatment. 
Dots represent single cells. Data represent two independent experiments. n = 7 – 16 
cells per condition per experiment. Error bars, standard deviation. ****P<0.0001, 
Student’s t-test. (C) Distribution of fluorescence intensities of ribosome-mRNA 
interaction spots for β-actin, with and without puromycin treatment. Representative 
data from one experiment. Control, n = 10 cells and 11,314 spots; puromycin, n = 7 
cells and 5,343 spots. 
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Figure 2.3 (previous page): Changes in FTH1 expression in response to added iron 
are detected by FLARIM. (A) Schematic of translational regulation of FTH1 mRNA 
by iron. (B) Images illustrating increase in ribosome-mRNA interaction for FTH1 
after iron treatment for 4 h (right) compared to a vehicle control (left). In the iron-
treated sample, there is a noticeable increase in detectable colocalization (yellow) 
between FTH1 mRNA transcript signals (red, Alexa 488 fluorescence) and 
ribosome-mRNA interaction signals (green, Alexa 546 fluorescence). Representative 
results from three independent experiments are shown. Scale bar = 20 µm. (C) 
Fraction of FTH1 mRNA transcript spots per cell colocalized with a ribosome-
mRNA interaction spot, with and without iron treatment over time. Dots represent 
single cells. Data represent three independent experiments. n = 10-17 cells per 
condition per experiment. Error bars, standard deviation. ****P<0.0001 (one-way 
ANOVA with Dunnett’s test). (D) Distribution of fluorescence intensities of 
ribosome-mRNA interaction spots for FTH1 in cells treated with iron for 4 h 
compared to a vehicle control. Representative results from one experiment. Vehicle, 
n = 17 cells and 3,503 spots; 4 h, n = 15 cells and 9,106 spots. (E) Changes in FTH1 
mRNA level per cell, with and without iron treatment for 4 h. Error bars, standard 
deviation. ***P<0.0002, ****P<0.0001 (one-way ANOVA with Dunnett’s test). 
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2.7 Supplemental Data and Figures 
 
Figure 2.S1: rRNA FISH in NIH 3T3 fibroblasts. (A) Schematic of experimental 
design to measure fluorescence from ribosome probes. Multiple ribosomes probes 
are hybridized to the 18S rRNA, but for illustration purposes, only a single probe is 
shown. (B) Fluorescence from antisense or sense probes for 18S rRNA. Green = 
ribosome signal, Blue = DAPI. Bright fluorescence signal is detected throughout cells 
with antisense probes. No signal is detected with sense probes. 
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Figure 2.S2: Schematic showing shared nucleotide sequences of ribosome probes 
and mRNA probes, as well as the sequence and binding location of the linker probe. 
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Figure 2.S3: Effect of formamide concentration in the linker hybridization buffer 
and wash solution on FLARIM results. Effect on (A) colocalization of β-actin mRNA 
transcript signals to background signal relative to ribosome-mRNA interaction signal 
and (B) hybridization of the β-actin mRNA transcript probes. In solutions with 25% 
and 30% formamide, the colocalization of β-actin transcript signals to ribosome or 
mRNA interaction probes alone may contribute significantly to the colocalization 
measured with both probes added. The buffer and wash solution with 40% 
formamide compromises hybridization of mRNA transcript probes, resulting in a 
significantly lower measure of mRNA transcripts per cell. Therefore, we chose 35% 
formamide for all experiments in this study. Error bars, standard deviation. For (A) 
and (B), n = 3-9 cells or 20-27 cells per measurement, respectively. 
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Figure 2.S4: Interaction of β-actin and FTH1 with ribosomes in cell nuclei. Confocal 
images of ribosome-mRNA interactions for β-actin (left) and FTH1 (right). Images 
show merged signals from Alexa 488 and Alexa 546 channels. Red = Alexa 488 
fluorescence from mRNA transcript probes. Green = Alexa 546 fluorescence from 
mRNA interaction probes. Yellow = colocalization of red and green indicating an 
mRNA with bound ribosomes. Circled red spots in the nucleus illustrate lack of 
ribosome interaction with these transcripts. Scale bar = 10 µm. The fraction of β-actin 
transcript spots colocalized with ribosomes in the nucleus is 0.12 ± 0.12 (n = 10 cells). 
The fraction of FTH1 transcript probes colocalized with ribosomes in the nucleus is 
0.12 ± 0.08 (n = 15 cells). 
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Figure 2.S5: Fraction of Arp3 transcript spots colocalizing with ribosome-mRNA 
interaction spots, when different probe sets are added: ribosome probes only, Arp3 
mRNA interaction probes only, or the combination of ribosome and Arp3 mRNA 
interaction probes. Error bars, standard deviation. Data represents three independent 
experiments, n = 20 – 31 cells per measurement. 
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Figure 2.S6: Colocalization between transcript probes and interaction probes for β-
actin and FTH1. (A) Schematic of experimental design to test extent of colocalization 
between mRNA interaction and transcript probes. Multiple interaction and transcript 
probes are hybridized to a single mRNA, but for illustration purposes, only a single 
probe per type is shown. (B) Average colocalization between β-actin mRNA probes 
in the cytoplasm. The fraction of β-actin transcript probes colocalized with 
interaction probes is 0.74 ± 0.03.  The fraction of interaction probes colocalized with 
transcript probes is 0.75 ± 0.03. Data represent two independent experiments, n = 8 
cells. (C) Average colocalization between FTH1 mRNA probes in the cytoplasm. 
The fraction of FTH1 transcript probes colocalized with interaction probes is 0.73 ± 
0.02.  The fraction of interaction probes colocalized with transcript probes is 0.74 ± 
0.04. Data represent three independent experiments, n = 20 cells.  
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Figure 2.S7: Levels of β-actin mRNA in control and puromycin-treated NIH 3T3 
fibroblasts. The average numbers (± standard deviation) of β-actin mRNAs per cell 
are 1999 ± 645 (n = 21 cells) and 1995 ± 608 (n = 23 cells) for control and puromycin-
treated cells, respectively. Differences in the values are not statistically significant, P 
= 0.9843. 
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Figure 2.S8: Effect of puromycin in combination with 4E1RCAT on interaction of 
β-actin mRNA with ribosomes. Fraction of β-actin mRNA transcript spots per cell 
colocalized with a ribosome-mRNA interaction spot after no treatment (Control), 
treatment with 200 ug/mL of puromycin for 1 h, or treatment 200 µg/mL of 
puromycin and 5 µM 4E1RCat for 1 h. n = 3-14 cells per measurement. Error bars, 
standard deviation. We thank a reviewer for suggesting this experiment. 
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Figure 2.S9: (A) Western blot and (B) quantification of increased FTH1 protein 
levels in NIH 3T3 cells treated with iron in the form of hemin at 50 µM for 4, 12, and 
24 h. Lysates were first blotted against primary antibodies for FTH1 and β-actin and 
then blotted against a goat anti-rabbit IgG secondary antibody coupled to Alexa 488. 
β-actin was used as a loading control. L = ladder, 1 = No treatment, 2 = 0.2% DMSO 
for 24 h (vehicle), 3 = 4 h hemin, 4 = 12 h hemin, 5 = 24 h hemin. We used 
ImageQuant TL software to quantify the fold change in FTH1 protein level per 
treatment condition compared to the control. We first performed a background 
subtraction of the Western blot with the rolling ball method to remove the baseline 
intensity. We then measured the integrated intensity of each band and determined the 
ratio of the FTH1 band intensity to the β-actin band intensity per lane. The fold 
change for each treatment condition was calculated by dividing its band intensity 
ratio for by the ratio of the control lane. 
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Figure 2.S10: Distribution of fluorescence intensities of ribosome-mRNA 
interaction spots for FTH1 in cells treated with iron for 4 h, 12 h, or 24 h compared 
to a vehicle control. Representative results from one experiment. Vehicle, n = 10 cells 
and 2770 spots; 4 h, n = 16 cells and 13360 spots; 12 h, n = 16 cells and 11392 spots; 
24 h, n = 15 cells and 11890 spots. 
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2.8 Supplemental Tables 
Table 2.S1: Sequences of all oligonucleotide probes used in Chapter 2. Provided as 
a separate Excel file. 
 
Table 2.S2: Probe sequences for human 18S rRNA. Provided as a separate Excel 
file. 
 
Table 2.S3: Fraction (average ± standard deviation) of putative β-actin transcripts 
(Alexa 488 spots) in the cytoplasm colocalized with Alexa 546 spots, which may 
correspond to linker probes or dye-labeled HCR hairpins, when only β-actin 
interaction probes, only ribosomes probes, or neither are added. Data represent two 
independent experiments. n = 4-6 cells per measurement per experiment. 
 Ribosome probes 
only  
mRNA interaction 
probes only  
Neither ribosome 
nor mRNA 
interaction probes 
(Linker + HCR 
background) 
Control 0.08 ± 0.01 0.07 ± 0.02 0.007 ± 0.003 
Puromycin 0.09 ± 0.03 0.09 ± 0.03 0.004 ± 0.002 
 
Table 2.S4: Fraction (average ± standard deviation) of putative FTH1 transcripts 
(Alexa 488 spots) in the cytoplasm colocalized with Alexa 546 spots, which may 
correspond to linker probes or dye-labeled HCR hairpins, when FTH1 interaction 
probes, ribosomes probes, or both are omitted. Data represent three independent 
experiments. n = 5-9 cells per measurement per experiment.  
 Ribosome probes 
only 
mRNA interaction 
probes only 
Neither ribosome 
nor mRNA 
interaction probes 
(Linker + HCR 
background) 
Vehicle 0.06 ± 0.02 0.02 ± 0.02 0.006 ± 0.004 
4h 0.06 ± 0.02 0.04 ± 0.01 0.005 ± 0.003 
12h 0.05 ± 0.02 0.04 ± 0.02 0.005 ± 0.003 
24h 0.07 ± 0.01 0.04 ± 0.01 0.005 ± 0.002 
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Table 2.S5: Fraction of ribosome-mRNA interaction spots colocalized with β-actin 
transcript spots with or without puromycin treatment. Data represent two independent 
experiments. n = 4-6 cells per measurement per experiment. 
 Fraction of spots 
Control 0.68 ± 0.04 
Puromycin 0.68 ± 0.03 
 
Table 2.S6: Fraction of ribosome-mRNA interaction spots colocalized with FTH1 
transcript spots after different treatments with iron. Data represent three independent 
experiments. n = 5-9 cells per measurement per experiment. 
 Fraction of spots 
Vehicle 0.54 ± 0.05 
4h 0.57 ± 0.04 
12h 0.55 ± 0.05 
24h 0.58 ± 0.03 
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2.9 Methods 
Dulbecco’s Modified Eagle Medium (DMEM) (#12491015), Fetal Bovine Serum 
(FBS) (#10438026), Penicillin-Streptomycin (5,000 U/mL) (#15070063), Trypsin-
EDTA (0.05%) (#25300054), RIPA buffer (#89900), and Human Plasma Fibronectin 
(#33016015) were purchased from ThermoFisher (Tustin, CA). SecureSeal 
hybridization chambers (8 well, 7mm x 7mm x 0.8mm, SKU 621503) were 
purchased from Grace BioLabs (Bend, OR), and 22mm x 50mm No. 1 glass 
coverslips were purchased from VWR (Brisbane, CA). All DNA oligonucleotide 
probes were designed using Stellaris Probe Designer version 4.2 (LGC Biosearch 
Technologies) and purchased from Integrated DNA Technologies (San Diego, CA). 
HCR hairpins were purchased pre-coupled to fluorophores from Molecular 
Instruments (Pasadena, CA). Formamide (SKU F9037), dextran sulfate (SKU 
D8906), puromycin (SKU P8833), hemin (SKU 51280), Benzonase Nuclease (SKU 
E1014) and cOmplete Protease Inhibitor Cocktail (SKU 4693116001) were 
purchased from Sigma-Aldrich (St. Louis, MO). Primary antibodies for FTH1 
(ab183781) and ACTB (ab8227) were purchased from Abcam (Burlingame, CA). A 
goat anti-rabbit IgG secondary antibody coupled to Alexa 488 (A-11034) was 
purchased from Life Technologies (Carlsbad, CA). 
Images were acquired on a Zeiss LSM 800 laser scanning confocal microscope 
operated by the Biological Imaging Facility of the Beckman Institute at Caltech. 
Imaging data were analyzed with the FISH-quant program written by Florian 
Mueller, the Cell Profiler program developed by the Broad Institute Imaging 
Platform, and the XPIWIT software tool developed by Johannes Stegmaier and the 
Center for Advanced Methods in Biological Image Analysis at the Beckman Institute 
(CAMBIA). 
Cell Culture. NIH 3T3 fibroblasts were grown in DMEM supplemented with 10% 
fetal bovine serum (FBS), 50 units/mL penicillin, and 50 µg/mL streptomycin at 37˚C 
in 5% CO2. Cells were passaged 2-3 times per week. In preparation for each imaging 
experiment, cells were trypsinized and transferred to glass coverslips pre-coated with 
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10 µg/mL human plasma fibronectin in 1X PBS, then grown on the coverslips 
overnight. 
For puromycin and hemin treatments, cells were grown on coverslips overnight and 
then the appropriate reagent was added directly to the cell culture medium. Cells were 
incubated with the reagents at 37˚C and 5% CO2. Puromycin was added at a final 
concentration of 200 µg/mL (from a stock 50-mg/mL solution in water) and left for 
1 h. Hemin was added at a final concentration of 25 µM (from a 50-mM stock 
solution in DMSO) and left for 4 h, 12 h, or 24 h. A vehicle control sample was 
incubated with 0.2% DMSO for 24 h. Hemin stocks were prepared fresh before each 
experiment.  
In Situ Hybridization and Hybridization Chain Reaction (HCR). Cells were 
fixed with 4% formaldehyde in 1X PBS for 30 min at room temperature (25°C). The 
reaction was quenched with 0.1 M glycine in 1X PBS for 5 min and then cells were 
washed once with 1X PBS. Fixed cells were permeabilized with 0.1% SDS in 1X 
PBS for 10 min with gentle rocking. Cells were washed once with 0.1% Triton in 1X 
PBS, then twice with 1X PBS. Cells were stored in 70% ethanol at 4˚C for at least 2 
h and up to 3 days before hybridization. 
For hybridization, coverslips were removed from ethanol and air dried. Secure-Seal 
hybridization chambers were attached to each coverslip. Cells were incubated 
overnight at 37˚C in a humid chamber with 1-2 nM/oligo of probes for ribosomes 
and mRNA in a hybridization buffer of 10% formamide and 10% dextran sulfate in 
2X SSC. 
The next day, the probe solutions were removed, and cells were washed three times 
with a solution of 35% formamide and 0.1% Triton in 2X SSC, then three times with 
2X SSC, to remove excess probes not bound to RNA. Cells were then incubated for 
30 min at 40˚C with a pre-heated solution of 10 nM linker probe in a hybridization 
buffer consisting of 35% formamide and 10% dextran sulfate in 2X SSC (“linker 
hybridization buffer”). After incubation, cells were washed three times with 0.1% 
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Triton in 2X SSC and twice with 2X SSC, then were left to cool for 15-20 min at 
room temperature. Cells were finally washed three times with 35% formamide and 
0.1% Triton in 2X SSC and three times with 2X SSC to remove any unbound or 
partially-hybridized linker probes. 
For HCR, the basic protocol of Choi and coworkers was followed with 
modifications17. Fluorescently labeled HCR hairpins were first snap-cooled (heated 
to 95˚C for 90 sec, then allowed to cool at room temperature for 30 min). The cells 
were then incubated for 1 h at room temperature (25˚C) with 85 nM hairpins in a 
hybridization buffer of 10% dextran sulfate in 2X SSC.  Following HCR, the cells 
were washed twice with 0.1% Triton in 2X SSC, incubated with 1 µg/mL DAPI for 
1 min, washed twice with 2X SSC, and then kept in 2X SSC for imaging. 
Western Blot. Cells were left untreated, incubated with 50-µM hemin (from a 50-
mM stock solution in DMSO) for 4 h, 12h, or 24h, or incubated with 0.2% DMSO 
for 24 h as a vehicle control. Cells were then washed with cold PBS and lysed in 
RIPA buffer supplemented with one cOmplete protease inhibitor tablet per 10 mL of 
buffer for 30 min on ice with gentle rocking. Lysates were collected using a cell 
scraper and were treated with 1 µL of Benzonase Nuclease per 500 µL of lysate for 
10 min at 37˚C. Lysates were heated in a loading buffer containing 50 mM Tris-HCl 
(pH 6.8), 2% SDS, 0.1% bromophenol blue, 10% glycerol, and 5% BME at 95˚C for 
10 min and immediately loaded onto a pre-cast SDS PAGE gel. Each lane was loaded 
with 15 µg of protein. After electrophoretic separation, proteins were transferred to a 
nitrocellulose membrane, which was blocked with 5% nonfat dry milk (NFDM) in 
PBS and 0.1% Tween-20 (PBST) for 1 h. The membrane was then incubated with a 
1/1000 dilution each of the FTH1 antibody and ACTB loading control in 5% NFDM 
in PBST overnight at 4˚C with gentle rocking. The next day, the membrane was 
washed three times with PBST for 10 min each with gentle rocking. The membrane 
was then incubated with an Alexa Fluor 488-conjugated secondary antibody at 
1/10,000 dilution in 5% NFDM in PBST at room temperature for 1 h. The membrane 
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was washed three times with PBST for 5 min each and imaged with a Typhoon Trio 
Imager. 
Fluorescence Imaging. All images were collected with a Zeiss LSM 800 laser 
scanning confocal microscope, using a 63X, NA 1.4 Plan-Apochromat objective. 
Resolution was set to 1024 x 1024 with a digital zoom of 0.7X and line averaging of 
2. Excitation laser sources and emission ranges were 405 nm/400-510 nm (DAPI, 
shown as blue), 488 nm/510-560 nm (Alexa 488, shown as red), and 561 nm/560-
700 nm (Alexa 546, shown as green). Each image was collected as a 3D stack of 15-
30 images with a spacing of 0.4 µm in the z-direction between slices. 
Image Analysis. Images were analyzed using the MATLAB-based program FISH-
quant59. Outlines of cells and nuclei were drawn manually in FISH-quant or 
automatically using Cell Profiler60. A 3D dual-Gaussian filter was used in FISH-
quant for background subtraction. Spots corresponding to ribosome-mRNA 
interactions or mRNA transcripts were identified by fitting with a 3D Gaussian 
function. The intensity and the width of the 3D Gaussian were thresholded to exclude 
autofluorescence and non-specific signals. Ribosome-mRNA interaction spots and 
mRNA transcript spots were identified independently and then analyzed for 
colocalization. The distance threshold for colocalization was set at 420 nm, which is 
equal to 3 pixels in all of our images. Raw intensity values were used for 
measurements of fluorescence intensity. For measuring colocalization of nuclear 
transcripts, a custom processing pipeline was implemented in the XPIWIT software 
tool to create a 3D mask based on DAPI fluorescence for each image61. The pipeline 
consisted of a median filter for noise reduction, a binarization of the image using 
Otsu’s method and a morphological closing to remove holes in the mask. The final 
3D mask was multiplied with the raw images, and thus only the spots within the 3D 
mask were kept for analysis. Any remaining spots on the edges of the nuclear mask 
were removed manually in FISH-quant before colocalization analysis.  
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C h a p t e r  3  
MONITORING LOCAL MRNA TRANSLATION IN SITU IN 
MOUSE HIPPOCAMPAL NEURONS 
3.1 Contributions 
The following work was conducted in close collaboration with Sophie 
Miller and Charlene Kim. Sophie and I performed the FLARIM experiments, and 
Charlene established the neuron cell cultures. Specifically, Sophie designed the 
probes for Arc, and I designed those for β-actin and MAP2. Sophie and I jointly 
performed the RNA/DNA hybridizations and cell preparation for all FLARIM 
experiments.  We also jointly collected images with the confocal microscope. 
Sophie was responsible for all data analysis of the following work, and I created the 
final images and figures. Charlene performed all the mice work. She regularly 
established primary hippocampal neuron cultures from embryonic mice and trained 
Sophie and me on properly plating the cells onto coverslips and maintaining the 
cultures before fixation. Charlene also assisted in writing the materials and methods 
section describing derivation of primary hippocampal cell cultures from embryonic 
mouse brain. 
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3.2 Summary 
Local translation of mRNA allows cells to establish a localized proteome in 
a specific subcellular compartment and rapidly modify that proteome in response to 
external stimuli. The importance of local translation is most apparent in neurons, 
where dendritic compartments far away from the nucleus must respond quickly to 
extrinsic signals that are restricted to those compartments. Dendrites and other 
neuronal processes contain thousands of different mRNAs; however, the regulation 
of individual mRNAs to produce protein at a particular location, time, or in 
response to a specific stimulus is not completely understood. We sought to test 
FLARIM in neuron cultures and apply the technique to characterize transcription 
and translation of particular mRNAs in these cells. Unlike other methods that have 
been used to study local translation in neurons, FLARIM is enzyme-free and does 
not require genetically modified organisms, genetic manipulation of cell cultures, 
nor application of drugs or modified nucleotides and amino acids.  We first 
demonstrate FLARIM in primary hippocampal neuron cultures by studying β-actin 
mRNA. We then use FLARIM to characterize the transcriptional and translational 
upregulation of activity-regulated cytoskeleton-associated protein (Arc) in response 
to application of Brain-derived neurotrophic factor (BDNF). These experiments 
illustrate that FLARIM can be applied to other cell types besides fibroblasts in our 
original work. We also compare the abundance and localization of two MAP2 
mRNA isoforms via FISH. In future work, we will apply FLARIM to determine if 
these isoforms have a differential localization and association with ribosomes in 
hippocampal neurons under certain environmental conditions. 
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3.2 Introduction 
Neurons are highly compartmentalized cells, with each compartment 
carrying out specialized functions. The major neuronal cell structures include the 
soma, axon, and dendrites1. The soma is a spherical cytoplasmic region that 
includes the nucleus and connects to the axon and dendrites. Neurons contain one 
axon but multiple dendrites, which further branch into multiple processes2. The 
axon is a long, thin extension of uniform width that branches at right angles from 
the cell body. Dendrites are shorter than the axon and appear thick near the cell 
body but become gradually thinner as they grow further away from the cell body3. 
The terminal ends of the axon contain synaptic vesicles that release 
neurotransmitters in response to electrical signals from the soma. The dendrites of 
neighboring neurons receive these neurotransmitters via receptors on the dendritic 
spines, which are small membranous protrusions along the length of the dendrite. 
This interaction forms the synapse: the space between the axon terminal and 
dendritic spine where signals are transmitted between one neuron to the other4. The 
axon forms the pre-synaptic terminal, and the dendrite forms the post-synaptic 
terminal2. To carry out complex signaling events, which are required for thought 
processing and autonomic functions, neurons must continually modulate the 
proteome in their different subcellular compartments. 
In vitro metabolic labeling experiments in the 1960s first demonstrated that 
de novo protein synthesis was possible in neuronal axons and dendrites5,6. 
Subsequently, polyribosomes were discovered at the base of dendritic spines via 
electron microscopy7. Local translation of mRNAs in neurons is now a widely 
accepted phenomenon, which is mediated by various mechanisms to place specific 
mRNAs at the proper site for translation8. Hundreds to thousands of different 
mRNAs in a neuron may localize to a specific subcellular site. For example, RNA 
sequencing has revealed that the axons and dendrites of hippocampal neurons 
contain over 2,500 different mRNAs9. Placing mRNAs in neuronal processes 
allows neurons to synthesize necessary proteins more quickly in response to 
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localized signals, as there is no need for these signals to travel to the nucleus to 
trigger mRNA synthesis and protein export. 
Some of the first mRNA transcripts identified to undergo local protein 
synthesis in neurons include calcium/calmodulin dependent protein kinase II alpha 
(CamKIIα), activity-regulated cytoskeleton-associated protein (Arc), and β-actin. 
The local synthesis of each of these transcripts is essential to neuronal function. 
CamKIIα mRNA localizes to dendrites through cis-acting sequences in its 3’ 
UTR10,11. The distal 170 nt of the CamKIIα 3’ UTR contain cytoplasmic 
polyadenylation elements (CPEs) to which the cytoplasmic polyadenylation 
element binding protein (CPEB) binds. CPEB facilitates dendritic transport as well 
as polyadenylation and translation of CamKIIα mRNA12,13. Local translation of 
CamKIIα is important for memory formation, as disruption of the 3’ UTR sequence 
in mice results in loss of CamKIIα localization to dendrites and reduced spatial 
memory, fear conditioning, and object recognition14. In comparison to CamKIIα 
regulation, where transcripts are primed at dendritic outposts for activity-induced 
translation15,16, Arc mRNA is rapidly transcribed in response to stimuli and then 
transported to activated post synaptic sites in dendrites for translation17,18. While the 
mechanism of Arc transcriptional activation is not completely understood, this 
activation relies on enhancer elements in the Arc promoter19,20. For transport into 
the dendrites, Arc is packaged with several proteins into a messenger 
ribonucleoprotein (mRNP) particle. The heterogeneous nuclear ribonucleoprotein 
(hnRNP) A2 binds to a region in the Arc CDS and facilitates kinesin-dependent 
mRNA transport21, while fragile-X mental retardation protein (FMRP) and Purα 
inhibit Arc translation during transport22,23. Like CamKIIα, local synthesis of Arc is 
important for memory formation. Reduction of Arc expression with antisense 
oligonucleotides impairs long-term potentiation (LTP) and consolidation of spatial 
memory24. Regulation of β-actin mRNA local translation is similar to the regulation 
of CamKIIα in that a trans-acting protein controls β-actin mRNA movement and 
expression. Zipcode binding protein 1 (ZBP1) binds β-actin mRNA, translationally 
represses it, and transports the mRNA to sites for protein synthesis. The 
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translational repression is relieved and β-actin is finally translated when ZBP1 is 
phosphorylated by Src kinase25,26. This local translation of β-actin is required for 
neuronal outgrowth and the movement of growth cones in response to attractive 
extracellular cues25,27. 
Microtubule associated protein 2 (MAP2) mRNA is another one of the 
initial mRNAs localized to dendrites28, and MAP2 protein is a well-known marker 
for dendrites but not axons29. However, the local translation of MAP2 mRNA 
within dendrites has not been completely characterized. MAP2 has two main 
mRNA isoforms: a low-molecular weight (LMW) isoform and a high-molecular 
weight (HMW) isoform. The LMW isoform, called MAP2c, is 6 kb long and 
encodes a protein of 70 kDa. The HMW isoform, called MAP2a/b, is 9 kb long and 
encodes a protein of 280 kDa30. The two isoforms are transcribed from a single 
gene by alternative splicing. The isoforms differ in their CDS, where MAP2a/b has 
an additional region that MAP2c lacks. MAP2a/b contains the same CDS sequence 
as MAP2c but also contains a unique, contiguous sequence of ~3 kb in between the 
5’ and 3’ ends of the MAP2c CDS. The LMW and HMW MAP2 mRNA isoforms 
appear at different stages of mouse brain development. While MAP2a/b is found in 
the cerebellum and cerebral hemispheres at all developmental stages, MAP2c is 
found at significant levels in these regions during only the first 1-2 postnatal 
weeks31. Furthermore, both the mRNA and protein of the MAP isoforms have been 
shown to occupy different regions of the brain32. The differential expression of the 
MAP2 isoforms suggests that they may have unique functions. It is possible that 
MAP2 isoform expression differs not only by time and cell type but also by 
subcellular location. However, the distribution of MAP2 mRNA isoforms within 
single cells and the local translation of these transcripts have not been 
characterized.  
We sought to visualize and characterize local translation of specific 
neuronal mRNAs via FLARIM. For this work, we used primary mouse 
hippocampal neuron cultures. We first validated FLARIM in these neurons by 
studying β-actin mRNA translation, which we had previously observed by 
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FLARIM in mouse fibroblasts. As in our original work, we found that significant 
FLARIM signals appear only when ribosome and mRNA probes are combined but 
not when either probe is alone. We then used FLARIM to monitor Arc mRNA 
expression in response to treatment with BDNF, which causes both a transcriptional 
and translation activation. Finally, we used FISH to compare the expression and 
localization of different MAP2 mRNA transcripts in cells. The translation of these 
transcripts will be compared via FLARIM in future work. 
 
3.3 Results and Discussion 
As described in Chapter 2, FLARIM utilizes pairs of oligonucleotide probes 
that bind separately to rRNA and to the mRNA of interest, and that produce strong 
fluorescence signals via the HCR when in close proximity. We use two types of 
mRNA probes per transcript of interest: (1) mRNA interaction probes, which target 
the CDS and pair with the ribosome probes to form binding sites for a linker probe 
that carries an HCR initiator, and (2) mRNA transcript probes, which target UTRs 
and separately label the mRNA transcript with a different HCR initiator. The 
ribosomes probes and mRNA interaction probes contain extension sequences 
outside of their RNA binding regions. A common extension sequence is used for all 
mRNA interaction probes, and a different extension sequence is used for all 
ribosome probes. We use a linker probe that hybridizes to these extension 
sequences on the mRNA interaction and ribosome probes in order to initiate HCR 
when the probes are in close proximity. For all of our experiments in neurons, we 
used the same set of 24 ribosome probes described in Chapter 2. These probes bind 
to relatively unstructured and chemically accessible regions of the mouse 18S 
rRNA. Unless otherwise stated, we used the same HCR initiators and fluorescently 
labeled hairpins as in Chapter 2. We used the B2 HCR initiator and its 
corresponding hairpins coupled to Alexa Fluor 488 for all mRNA transcript probes, 
and we used the B3 HCR initiator and its corresponding HCR hairpins coupled to 
Alexa Fluor 546 to amplify fluorescence signals associated with the linker probe. 
Signals from the linker probes and from mRNA transcript probes appear as single, 
62 
 
diffraction-limited spots when visualized by confocal microscopy (Fig 3.1B). In the 
ideal FLARIM scheme, spots that colocalize in the Alexa 488 (shown in red 
throughout this study) and Alexa 546 (shown in green throughout this study and 
referred to as ‘FLARIM’ signals) channels indicate mRNAs bound to ribosomes; 
spots that appear only in the Alexa 488 channel indicate mRNAs that do not 
interact with ribosomes. Sequences of all oligonucleotide probes used in this 
Chapter are listed in Table 3.S1. 
We first tested FLARIM in primary mouse hippocampal neurons using 
probes designed for β-actin mRNA. We used the same set of β-actin mRNA probes 
described in Chapter 2.  Control experiments in which either the mRNA interaction 
probes or the ribosome probes were omitted showed little or no labeling from the 
linker probe. However, when both ribosome and mRNA interaction probe sets were 
added, we saw a significant increase in FLARIM signals from the linker probe 
(Figure 3.1A) and substantial colocalization of these signals with those derived 
from the β-actin transcript probes (Figure 3.1C). These results are similar to those 
obtained in mouse fibroblasts in Chapter 2 and illustrate that the linker washes out 
of cells when it binds only to an mRNA interaction probe or to a ribosome probe, 
but it remains stably bound when both probe sets are present. We found on average 
that 45 ± 6% (n = 8 cells) of β-actin transcripts per cell were colocalized with 
ribosomes. Colocalized spots appeared in both the cell soma and dendrites (Fig 
3.1B). In comparison, the samples with ribosome probes or mRNA interaction 
probes alone produced punctate Alexa 546 emission to which only 2 ± 1% (n = 9) 
and 5 ± 2% (n = 8) of Alexa 488 spots colocalized, respectively (Figure 3.1C, Table 
3.2). In addition, cells treated with the linker probe alone produced fewer than 10 
spots of Alexa 546 emission per cell, and less than 0.5% of Alexa 488 spots 
colocalized to these Alexa 546 spots (Table 3.2). Hence, the levels of false positive 
signals arising from nonspecific binding of the linker, or from the HCR 
amplification step, are negligible. 
We next tested the sensitivity of FLARIM to detect changes in mRNA 
expression in neurons. We chose to study Arc, a well-characterized neuronal 
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transcript known to undergo both transcriptional and translational regulation in 
response to neuronal stimulation18. In particular, application of BDNF to cultured 
neurons enhances synthesis of Arc mRNA and protein33. In experiments with 
synaptoneurosomes, which are synaptic vesicles mechanically separated from the 
cell body, BDNF directly modulates the dendritic translation of Arc34. BDNF is a 
key protein in the family of neurotrophic factors and is involved in neurogenesis, 
neuron growth and survival, and learning and memory. BDNF modulates gene 
expression by binding and activating TrkB receptors found on axons, nerve 
terminals, and dendritic spines. Activated TrkB receptors trigger multiple signaling 
pathways that lead to the expression of particular mRNAs and proteins35,36. 
We grew neurons to DIV 4-5 and then added BDNF at a final concentration 
of 100 ng/mL to the cell culture media for 1 h before fixing and processing the cells 
for FLARIM experiments. We detected a noticeable and statistically significant 
(P<0.05, Student’s t-test) increase the in the interaction of Arc mRNA with 
ribosomes in cells treated with BDNF (Figure 3.2A). After 1 h of treatment, the 
fraction of Arc mRNAs interacting with ribosomes increased from an average of 3 
± 4% to an average of 16 ± 8% (Figure 3.2B, Table 3.3). The fraction of Arc 
mRNAs interacting with ribosomes in the untreated samples is comparable to 
background levels from the control samples where either ribosome or mRNA 
interaction probes are omitted (Figure 3.2B, Table 3.3). Hence, we conclude that 
there is no significant translation of Arc in untreated neurons. However, upon 
stimulation with BNDF, Arc mRNA translation is significantly upregulated. 
We also measured the number of Arc mRNAs per cell, which corresponds 
to the number of mRNA transcript spots detected. In untreated cells, we detected an 
average of 107 ± 54 Arc mRNAs per cell. In BDNF-treated cells, we detected 
average of 62 ± 41 Arc mRNAs per cell. This nearly 2-fold increase in the number 
of Arc mRNAs after BDNF treatment was visibly noticeable but not statistically 
significant (P = 0.2411, Student’s t-test). However, this may be due to a limited 
number of cells analyzed (n = 4 cells without BDNF; n = 6 cells with BNDF). 
Additional experiments will be performed to determine if the results are repeatable 
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and if the observed difference between Arc expression with and without BDNF is 
statistically significant. Nevertheless, FLARIM reveals distinct increases in Arc 
mRNA abundance and ribosome association, which are expected after neuronal 
activation with BDNF. As with our studies of FTH1 in Chapter 2, we demonstrate 
that FLARIM is useful in assessing both transcriptional and translational control of 
gene expression in single cells. 
We next sought to investigate the local translation of MAP2 mRNA in 
neurons. MAP2 is a common marker for dendrites but its mRNA translation has not 
been completely characterized. In particular, MAP2 has two mRNA isoforms, 
which have unique spatial and temporal expression patterns in the brain30–32 and 
may undergo distinct regulation within single cells as well. These mRNA isoforms 
can be distinguished in single cells via smFISH. The HMW isoform, termed 
MAP2a/b, contains an additional 3kb region in its CDS compared to the LMW, 
termed MAP2c. All other sequences between the two isoforms are identical. In 
order to distinguish these isoforms, we designed three unique mRNA probe sets for 
MAP2: one set hybridizes to the shared CDS region between the two isoforms 
(designated “common CDS probes”), a second set hybridizes only to the unique 
CDS region of the HMW MAP2 isoform (designated “MAP2a/b unique CDS 
probes”), and a final set hybridizes to the 3’UTR (designated “common 3’UTR 
probes”), which is identical between the isoforms. Figure 3A illustrates the general 
locations of these probes along the MAP2 mRNA isoforms. The common CDS 
probes contain the extension sequence that is used for mRNA interaction probes in 
FLARIM. These probes can thus to be used to detect ribosome interactions with 
any MAP2 transcript, regardless of which isoform it is. The MAP2a/b unique CDS 
probes contain the B1 HCR initiator and were visualized with the corresponding B1 
hairpins coupled to Alexa Fluor 647. The common 3’UTR probes contain the B2 
HCR initiator and were visualized with the corresponding B2 hairpins coupled to 
Alexa Fluor 488. To visualize the common CDS probes in smFISH experiments, 
we used a linker probe that is complementary to 24 nt of the extension sequence, 
similar to the experiments described in Figure 2.S6 of Chapter 2 and illustrated in 
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Figure 3.1A. This linker contains the B3 HCR initiator and was visualized with the 
corresponding B3 hairpins coupled to Alexa 546. 
In a smFISH experiment with the above probes, we found that the 71 ± 4% 
of Alexa 546 spots (from the shared CDS probes) colocalized with Alexa 488 spots 
(from the common 3’UTR probes). In an ideal smFISH experiment, 100% of 
fluorescence signals from the shared CDS probes would colocalize with signals 
from the common 3’UTR probes, as all MAP2 transcripts to contain the sequences 
targeted by these two probe sets. However, as explained in Chapter 2, fluorescence 
signals generated by smFISH and smHCR invariably yield less than 100% 
colocalization for probes targeted to the same message19,39,43.  In comparison, we 
found that only 44± 4% of Alexa 546 spots colocalized with Alexa 647 spots (from 
the MAP2a/b unique CDS probes), suggesting the MAP2 mRNA isoforms are 
expressed at different levels in hippocampal neurons. Our colocalization results 
were similar for MAP2 transcripts in the cell soma versus dendrites (Figure 3.6D). 
In both regions, approximately 70% of Alexa 546 signals from the common CDS 
probes colocalized to Alexa 488 signals from the 3’UTR probes, and approximately 
40% of Alexa 546 signals from the common CDS probes colocalized to Alexa 647 
signals from the MAP2a/b unique CDS probes. We will conduct additional 
experiments to further support these observations. Subsequently, we will conduct 
FLARIM experiments using the common CDS probes to detect interaction of 
MAP2 mRNAs with ribosomes. These experiments will illustrate whether the two 
isoforms display a unique translational regulation in addition to transcriptional 
regulation.  
Various RNA binding proteins mediate the dendritic localization of MAP2 
mRNA, but the mechanism by which the two major isoforms are uniquely 
distributed and expressed is not known. Both MAP2 mRNA isoforms contain a 
640-nt dendritic targeting element to which the proteins MARTA1 and MARTA2 
bind37,38. MARTA2 has been directly implicated in the transport of MAP2 via 
interaction with the microtubule-based motor KIF539. However, the 3’UTR 
interactions with MARTA1 and MART2 do not explain how MAP2a/b and MAP2c 
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localize to different cellular regions, as these transcripts contain an identical 
3’UTR. If the MAP2a/b and MAP2c demonstrate a significant difference in their 
localization patterns, then the additional CDS region of MAP2a/b may provide an 
additional targeting function. Alternatively, the transcripts may not demonstrate a 
particular localization pattern but their translation may be modulated based on the 
presence or absence of the additional CDS region. Another hypothesis is that the 
transcripts are alternatively spliced after localization. In this case, the additional 
CDS region may be removed from or retained in MAP2 transcripts based on when 
and where they will be expressed. Several genes retain introns in their cytoplasmic 
mRNAs, and while the activity of the spliceosome in the cytoplasm is still debated, 
these mRNAs may be subject to extranuclear splicing40. Splicing factors and 
components of the spliceosome have been identified in dendrites, and isolated 
dendrites are capable of splicing reporter pre-mRNAs41. A local splicing event of 
MAP2 would obviate the need to shuttle to the nucleus for processing. Intriguingly, 
MARTA1 is the homologue of a splicing regulatory protein in humans42. 
 
3.4 Conclusion and Future Directions 
This work shows that our method FLARIM, which visualizes and quantifies 
changes in ribosome association with endogenous, unmodified mRNAs in situ 
using standard DNA oligonucleotide probes and HCR, can be applied to primary 
mouse hippocampal neurons. We had previously characterized FLARIM in NIH 
3T3 mouse fibroblasts. In working with neurons compared to fibroblasts, we used 
the same probe design, as well as many of the same sequences, and followed the 
same FLARIM procedure, excluding slight modifications in the cell fixation and 
permeabilization steps. This supports that FLARIM can be directly applied to 
different cell culture systems without significant modifications. In future work, we 
aim to perform FLARIM experiments in cells from different tissues and species, 
particularly human, to further support this conclusion. Regardless, FLARIM is 
designed such that the method is highly tunable. Probe sequences, as well as the 
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concentration of formamide in buffer and wash solutions, can be easily modified to 
ensure that HCR amplification occurs essentially only from interacting probe pairs. 
In our primary mouse hippocampal neuron cultures, we first demonstrated 
that FLARIM works in these cells by measuring ribosome-mRNA interactions for 
β-actin. We then detected increased transcription and ribosome binding to Arc 
mRNA when cells were treated with BDNF. This demonstrates how FLARIM 
interrogates both transcription and translation of mRNAs and thus provides unique 
insights into the nature of gene regulation in single cells. We plan to conduct 
similar experiments for CamKIIα mRNA, which shows a translational response to 
BDNF treatment43. Finally, we measured the distribution of MAP2 mRNA variants 
in our neuron cultures. We found that 44% of the MAP2 mRNAs in primary 
hippocampal neurons are the MAP2a/b isoform, which contains an additional 3 kb 
region in the CDS region compared to the MAP2c isoform. The remaining MAP2 
mRNAs are presumably the MAP2c isoform. Our initial results also suggest that 
this distribution of MAP2a/b and MAP2c is similar between the soma and 
dendrites. However, these results reflect a sample of only 11 cells in one 
experiment. We plan to validate that these results are consistent in repeated 
experiments. We will then use FLARIM to compare the ribosome association of 
MAP2 isoforms in hippocampal neurons. FLARIM is well suited to compare the 
expression of mRNA isoforms that can be distinguished by smFISH. In 
comparison, methods that require genetic manipulations of mRNA to visualize 
translation often cannot differentially label unique isoforms produced from the 
same gene. For instance, current methods that visualize mRNA by tagging its 
3’UTR44–48 would not be able to distinguish the MAP2 variants, which differ in 
their CDS. The mechanisms that control MAP2 mRNA isoform expression in 
hippocampal neurons are not completely known, but they may involve RNA 
binding proteins that uniquely distribute the two variants and or regulate their 
translation. They may also involve dendritic splicing of localized transcripts, as the 
known dendritic targeting sequence of MAP2 resides in the 3’UTR that is shared 
between all variants. Upon characterizing the expression of MAP2 isoforms more 
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thoroughly in FLARIM experiments, we can use additional molecular biology 
techniques to understand how the observed expression pattern is accomplished. 
In working with neurons, we anticipate that FLARIM will be useful to 
compare the local translation of mRNAs in different subcellular compartments. 
Beyond comparing expression of mRNAs in dendrites versus the soma, we may 
also be able to compare expression in dendritic spines versus the dendritic shaft. 
The shaft is the long and thin membranous protrusion from the soma, while spines 
are nodes along the dendritic shaft where dendrites receive information from 
adjacent neurons1. Spines are typically 0.5 – 2 µm in length, 0.01 – 0.8 µm3 in 
volume and occupy a density of up to 10 spines per µm along the dendritic shaft in 
mature neurons49. In order to resolve these structures and also enhance the 
resolution of FLARIM, we can apply expansion FISH (ExFISH)50 to our samples. 
With this technique, RNA in cells is covalently attached to a polyelectrolyte gel that 
is synthesized within the cells. The gel is osmotically swelled, thereby increasing 
the physical distance between biomolecules and improving the resolution of mRNA 
imaging by a factor of ~3.3X. ExFISH uses HCR and has been already been applied 
to mouse brain tissue, supporting that this method will be compatible with 
FLARIM studies in neurons. 
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3.6 Figures 
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Figure 3.1 (previous page): Demonstration of FLARIM in neuron cultures. (A) 
Primary mouse hippocampal neurons hybridized with either ribosome probes, 
mRNA interaction probes to β-actin, or both ribosome and β-actin mRNA 
interaction probes (top, green, Alexa 546 fluorescence). Cells are simultaneously 
hybridized with β-actin transcript probes (middle, red, Alexa 488 fluorescence). 
Cell bodies and dendrites are labeled with an anti-MAP2 primary antibody (blue). 
Merge of ribosome-mRNA interaction signals and transcript signals (bottom). Scale 
bar = 10 µm. (B) Zoom of single mRNA molecules in the soma (top) and dendrites 
(bottom). Zoomed-in images correspond to the boxed regions in the merge of the 
ribosome + mRNA interaction probes picture in (C). Red spot: mRNA transcript 
without ribosome interaction, indicated by an arrow. Yellow spots: mRNA 
transcripts with ribosome interaction, indicated by an arrowhead. Scale bar = 0.5 
µm. (C) Fraction of β-actin transcript spots colocalized with ribosome-mRNA 
interaction spots per cell. Error bars, standard deviation. 
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Figure 3.2 (previous page): Changes in Arc mRNA expression in response to 
added BNDF are detected by FLARIM. (A) Images illustrating increase in 
ribosome-mRNA interaction for Arc after iron treatment with 100 ng/mL BDNF for 
1 h (right) compared to an untreated control (left). In the BDNF-treated sample, 
there is a noticeable increase in detectable colocalization (yellow) between Arc 
mRNA transcript signals (red, Alexa 488 fluorescence) and ribosome-mRNA 
interaction signals (green, Alexa 546 fluorescence). There is also a noticeable 
increase in the total number of Arc mRNAs (red and yellow spots). Top, scale bar = 
10 µm. Bottom, scale bar = 5 µm. (B) Fraction of Arc mRNA transcript spots per 
cell colocalized with a ribosome-mRNA interaction spot, with and without BDNF 
treatment. Dots represent single cells. Error bars, standard deviation. *P < 0.0138, 
Student’s t-test. (C) Changes in Arc mRNA level per cell, with and without BDNF 
treatment. Dots represent single cells. Error bars, standard deviation. 
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Figure 3.3 (previous page): smFISH detection of MAP2 mRNA isoforms in 
neurons. (A) Schematic of the smFISH probe design for MAP2a/b (top) and Map2c 
(bottom). MAP2a/b contains an additional 3 kb sequences in its CDS compared to 
MAP2c. This region can be targeted with a unique set of probes and fluorophore. 
Hence, MAP2a/b mRNAs are identified by the colocalization of three fluorescent 
spots: green (Alexa 546), cyan (Alexa 647), and red (Alexa 488). MAP2c is 
identified by the colocalization of two fluorescent spots: green (Alexa 546) and red 
(Alexa 488). (B) Confocal image of MAP2 smFISH in a primary hippocampal 
neuron culture. Boxed regions in the images on the left are zoomed in to create the 
images on the right. Bottom images are a merge with MAP2 antibody staining 
(magenta). Left, scale bar = 10 µm. Right, scale bar = 2 µm. (C) Fluorescence 
profile of the line drawn through spots in the top right image of (B). The profile 
shows fluorescence intensities of each fluorophore from left to right along the line. 
The spot on the left demonstrates colocalization between green and red, indicating 
MAP2c. The spot on the right demonstrates colocalization between green, cyan, 
and red, indicating MAP2a/b. The left vertical axis reflects fluorescence intensities 
of Alexa 488 and Alexa 546. The right vertical axis reflects the fluorescence 
intensity of Alexa 647. 
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3.7 Tables 
Table 3.1: Sequences of all oligonucleotide probes used in Chapter 3. Provided as a 
separate Excel file. 
 
Table 3. 2: Fraction (average ± standard deviation) of putative β-actin transcripts 
(Alexa 488 spots) in mouse hippocampal neuron preparations colocalized with 
Alexa 546 spots, which may correspond to linker probes or dye-labeled HCR 
hairpins, when only β-actin interaction probes, only ribosomes probes, or neither 
are added. n = 3-6 cells per measurement. 
 
Ribosome probes 
only  
β-actin mRNA 
interaction probes 
only  
Neither ribosome nor mRNA 
interaction probes (Linker + HCR 
background) 
0.02 ± 0.01 0.05 ± 0.02 0.002 ± 0.002 
 
Table 3. 3: Fraction (average ± standard deviation) of putative Arc transcripts 
(Alexa 488 spots) in mouse hippocampal neuron preparations colocalized with 
Alexa 546 spots, which may correspond to linker probes or dye-labeled HCR 
hairpins, when Arc interaction probes, ribosomes probes, or both are omitted. n = 3-
6 cells per measurement.  
 
Ribosome probes 
only 
Arc mRNA 
interaction probes 
only 
Neither ribosome nor mRNA 
interaction probes (Linker + HCR 
background) 
0.06 ± 0.02 0.02 ± 0.02 0.003 ± 0.003 
 
Table 3.4: Fraction of ribosome-mRNA interaction spots colocalized with Arc 
mRNA transcript spots with or without BDNF treatment. Data represent two 
independent experiments. n = 4-6 cells per measurement per experiment. 
 
 Fraction of spots 
Control 0.03 ± 0.04 
BDNF 0.16 ± 0.08 
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3.8 Methods 
Neurobasal medium (Gibco, #21103-049), GlutaMAX (Gibco, #35050-061), B27 
(Gibco, #17504-044), Donor Equine Serum (SH30074.03) and HBSS (Gibco, 
#14175-095) were purchased from Thermo Fisher Scientific (Carlsbad, CA). 
SecureSeal hybridization chambers (8 well, 7mm x 7mm x 0.8mm, SKU 621503) 
were purchased from Grace BioLabs (Bend, OR). Multiwell cell culture plates (6-
well, #10062-892) and 22mm x 22mm No. 2 glass coverslips (#48368-062) were 
purchased from VWR (Brisbane, CA). All DNA oligonucleotide probes were 
designed using Stellaris Probe Designer version 4.2 (LGC Biosearch Technologies) 
and purchased from Integrated DNA Technologies (San Diego, CA). HCR hairpins 
were purchased pre-coupled to fluorophores from Molecular Instruments 
(Pasadena, CA). Formamide (SKU F9037), dextran sulfate (SKU D8906), Triton 
X-100 (SKU T8797), poly-D-lysine hydrobromide (SKU P6407), poly-L-ornithine 
(SKU P4957), laminin (SKU L2020), brain-derived human neurotrophic factor 
(BDNF) (SKU B3795), L-Ascorbic acid (SKU A7506), DNAse I (SKU DN25), 
and BSA (SKU A7030) were purchased from Sigma-Aldrich (St. Louis, MO). 
Papain was purchased from Worthington Biochemical Corporation (Lakewood, 
NJ). 16% paraformaldehyde (#15710) was purchased from Electron Microscopy 
Sciences. A primary antibody for MAP2 (ab32454) and a donkey anti-rabbit IgG 
secondary antibody coupled to Alexa 405 (ab175651) were purchased from Abcam 
(Burlingame, CA).  
Images were acquired on a Zeiss LSM 800 laser scanning confocal microscope 
operated by the Biological Imaging Facility of the Beckman Institute at Caltech. 
Imaging data were analyzed with the FISH-quant program written by Florian 
Mueller. 
Derivation of Primary Hippocampal Cell Cultures from Embryonic Mouse 
Brain. Prior to obtaining cells, coverslips were rinsed with 70% EtOH, dried, 
placed into single wells of 6-well plates, and finally sterilized under UV light for 
10-15 min. The coverslips were then coated with 0.1 mg/mL poly-D-lysine 
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overnight at 37˚C. The following morning, poly-D-lysine was aspirated from the 
coverslips, which were then coated with poly-L-ornithine for 1 h at 37˚C, rinsed 
twice with sterile water, and coated with 0.01 mg/mL laminin for at least 1 h at 
37˚C before plating cells. 
A pregnant mouse was euthanized on gestational day 16 using CO2. The abdomen 
of the euthanized mouse was sprayed with 70% EtOH and cut laterally and 
proximally on both sides. The uterus was removed from the abdomen by cutting the 
ends of the uterine horn and was placed in a petri dish in a sterile hood. The embryo 
sac was removed from the uterus, and the embryonic mice were decapitated by 
pinching at the neck with forceps. For each mouse, the skin and skull surrounding 
the brain were removed with forceps, and the forebrain was removed and placed in 
a petri dish with cold HBSS under a dissecting microscope. Meninges and 
vasculature were removed, and the hippocampus was isolated and cut with forceps 
into four sections of roughly equal size. 
The quartered hippocampal sections were placed into a 15 mL conical tube. After 
the sections settled, HBSS was removed and 500 µL of 15 units/mL papain in 
HBSS was added to the tube. The tube was placed into a water bath at 37˚C for 15 
min. Cells then resuspended by flicking the tube after 7.5 min. The hippocampal 
sections were then pipetted into a 1 mL solution of 1 mg/mL DNase and allowed to 
settle to the bottom of the tube. The sections were then rinsed by transferring them 
into a 15 mL tube containing 1 mL of 10% donor equine in HBSS. This rinse was 
repeated after allowing the sections to settle to the bottom of the tube. The cells 
were then triturated by pipetting up and down 7 times. A 200-µL aliquot of 4& 
BSA was slowly pipetted into the bottom of the tube. The cells were then 
centrifuged at 280 x g for 6 min. The supernatant was aspirated, and the cells were 
resuspended in 1 mL of Neurobasal medium supplemented with 0.5 mM 
GlutaMAX and 1% donor equine serum (plating medium). Cells were counted with 
a hemocytometer, and the cell suspension was diluted to 600 cells/µL with plating 
medium. 
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For plating cells, laminin was aspirated from the coated coverslips in batches of two 
coverslips at a time. Cells were plated onto the coverslips immediately after 
aspirating in order to prevent coverslips from drying out. 1 mL of cells at a density 
of 6 x 105 cells/coverslip was added to each well. After 1 h, 2 mL of plating 
medium supplemented with B27 (diluted by 50X) and 17.6 mg/mL ascorbic acid 
(culture medium) was added to each well. The final primary hippocampal neuron 
cultures were grown at 37˚C in 5% CO2. Half of the medium in each well was 
exchanged with fresh culture medium every 2-4 days.  
In Situ Hybridization and Hybridization Chain Reaction (HCR). Primary 
hippocampal neurons were fixed at DIV 4-5 with 4% formaldehyde, 5% sucrose in 
1X PBS for 20 min at room temperature (25°C). For neuronal stimulation 
experiments, cells were incubated with BDNF at 100 ng/mL for 1 h at 37˚C and 5% 
CO2 prior to fixing. After fixation, cells were washed three times with 1X PBS. 
Fixed cells were permeabilized with 0.1% Triton in 1X PBS for 10 min with gentle 
rocking. Cells were then washed three times with 1X PBS. Cells were stored in 
70% ethanol at 4˚C for at least 2 h and up to 2 days before hybridization. 
For hybridization, coverslips were removed from ethanol and air dried. Secure-Seal 
hybridization chambers were attached to each coverslip. Cells were incubated 
overnight at 37˚C in a humid chamber with 1-2 nM/oligo of probes for ribosomes 
and mRNA in a hybridization buffer of 10% formamide and 10% dextran sulfate in 
2X SSC. 
The next day, the probe solutions were removed, and cells were washed three times 
with a solution of 35% formamide and 0.1% Triton in 2X SSC, then three times 
with 2X SSC, to remove excess probes not bound to RNA. Cells were then 
incubated for 30 min at 40˚C with a pre-heated solution of 10 nM linker probe in a 
hybridization buffer consisting of 35% formamide and 10% dextran sulfate in 2X 
SSC (“linker hybridization buffer”). After incubation, cells were washed three 
times with 0.1% Triton in 2X SSC and twice with 2X SSC, then were left to cool 
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for 15-20 min at room temperature. Cells were finally washed three times with 35% 
formamide and 0.1% Triton in 2X SSC and three times with 2X SSC to remove any 
unbound or partially-hybridized linker probes. 
For HCR, the basic protocol of Choi and coworkers was followed with 
modifications51. Fluorescently labeled HCR hairpins were first snap-cooled (heated 
to 95˚C for 90 sec, then allowed to cool at room temperature for 30 min). The cells 
were then incubated for 1 h at room temperature (25˚C) with 85 nM hairpins in a 
hybridization buffer of 10% dextran sulfate in 2X SSC.  Following HCR, the cells 
were washed twice with 0.1% Triton in 2X SSC, incubated with 1 µg/mL DAPI for 
1 min, washed twice with 2X SSC, and then kept in 2X SSC for imaging. 
Antibody Staining. After RNA in situ hybridization and HCR, cells were stained 
with a MAP2 antibody to label dendrites. Cells were first blocked with 1% BSA in 
PBS at room temperature for 30 min. The cells were then incubated with a primary 
polyclonal anti-MAP2 antibody at a final concentration of 10 µg/mL in 1% BSA 
for 1 h. The primary antibody solution was removed, and the cells were washed 
three times with 1X PBS. The cells were then incubated with a secondary IgG 
antibody coupled to Alexa 405 at a final concentration of 4 µg/mL in 1% BSA for 1 
h. The secondary antibody solution was removed, and the cells were washed three 
times with 1X PBS. Cells were kept in PBS for imaging.  
Fluorescence Imaging. All images were collected with a Zeiss LSM 800 laser 
scanning confocal microscope, using a 63X, NA 1.4 Plan-Apochromat objective. 
Resolution was set to 1024 x 1024 with a digital zoom of 0.7X and line averaging 
of 2. Excitation laser sources and emission ranges were 405 nm/400-510 nm (Alexa 
405, shown as blue or magenta), 488 nm/510-560 nm (Alexa 488, shown as red), 
561 nm/560-700 nm (Alexa 546, shown as green), and 650 nm (Alexa 647, shown 
as cyan). Each image was collected as a 3D stack of 15-30 images with a spacing of 
0.4 µm in the z-direction between slices. 
Image Analysis. Images were analyzed using the MATLAB-based program FISH-
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quant52. Outlines of cells and nuclei were drawn manually in FISH-quant. A 3D 
dual-Gaussian filter was used in FISH-quant for background subtraction. Spots 
corresponding to ribosome-mRNA interactions or mRNA transcripts were 
identified by fitting with a 3D Gaussian function. The intensity and the width of the 
3D Gaussian were thresholded to exclude autofluorescence and non-specific 
signals. Ribosome-mRNA interaction spots and mRNA transcript spots were 
identified independently and then analyzed for colocalization. The distance 
threshold for colocalization was set at 420 nm, which is equal to 3 pixels in all of 
our images. Raw intensity values were used for measurements of fluorescence 
intensity. 
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